Scott who? The company used to have a ceo named Scott but it's been so long since we heard from him I wont be surprised to find out he is living in Belize drinking rum. He dam sure isnt working on anything to do with echo.
Go to Ecte Revivalists board on Investor village. There is a link at the top to Marcum presentation the CEO did May 27.,At 16 minutes in the presentation Mr. Hollander said he was heading to China on Saturday.
They moved out of the Philly office that cost $15,000 a month and moved into the Iselin office for $7,500 a month. Cutting the rent in half is smart money management.
Sentiment: Strong Buy
If you bought at $4.50 a share you're the worst trader I've ever seen. It was at 4.50 for like a day and that was the high. LOL. Man you need to sell and go buy CD's. You'll do better. LOL
So? I worked for Enron for 8 years. Now I manage 2,100 people for a Fortune 100 company. What's your point??
I've never seen a buyout that was bad news. LOL. IMO the value of ATL to any buyer is at least 75 cents maybe as high as 90 cents. You also got it wrong about Amplats. They do not have a stake in ATL. Amplats and ATL own a mining operation together. Amplats is considering selling their portion of the mine if they can get a premium price. That would be great for ATL if that happens.
ECTE was $40 two years ago. Platinum said today they are looking for a return to $30 at least once they are in charge.
Ask Laurel Hill
GOOG following ECTE imho. Needles are going the way of horse buggies.
The latest project from Google X is a smart contact lens, a tiny, flexible computer capable of monitoring glucose levels in tears. Researchers at Google are hopeful that one day this technology might be used to help diabetes patients better control their disease.
"I think the Google X device could be a huge game changer," says Dr. John Buse, professor of medicine at the University of North Carolina School of Medicine. He's also chairman of the National Diabetes Education Program for the National Institutes of Health and the Centers for Disease Control and Prevention.
Buse and Google researchers are quick to point out that years of basic research remain before this device or one like it comes to market. At the moment, even the relationship between the level of glucose in tears and blood glucose levels remains unproven.
Nonetheless, the tiny wireless computer embedded on a soft contact lens represents a remarkable technical achievement.
Scientists at Google unveiled their prototype Thursday.
"At this point, we have functional prototypes," said Brian Otis, the project lead at Google X. "We have integrated circuits that have been miniaturized to the point where they look like a piece of glitter integrated inside the soft contact lens material."
The smart lens consists of this glitter-fleck-sized wireless computer chip as well as a microscopically small glucose sensor and an antenna thinner than a human hair. All of this is embedded between two layers of soft-contact lens material.
"We have a glucose sensor that has to be much more sensitive — because the concentration of glucose in tears is much lower than the concentration in blood. We've also created a way of tying all of these technologies together in a flexible platform," Otis said — so flexible and soft that you could slip it over your eye.
A loan? Fat chance. They have no cash flow to repay a loan. Negative assets and net worth. No bank would touch them. The offering will be priced at the normal 20% discount. Look for a deal around 2.40 imho.